Group 1 - The Shanghai Composite Index rose by 0.96% to close at 3617.6 points, while the Hang Seng Index increased by 0.68% to 24902.53 points [1] - Longyuan Power's A/H share premium reached 156.68%, ranking ninth among A/H shares [1] - Longyuan Power's A-shares closed at 16.5 yuan, with a gain of 0.61%, and H-shares closed at 7.02 HKD, up by 0.57% [1] Group 2 - Longyuan Power Group Co., Ltd. was established in 1993 and has undergone several ownership changes, currently under the State Energy Group [1] - The company successfully listed on the Hong Kong main board in 2009 and was recognized as "China's first new energy stock" [1] - In 2022, Longyuan Power officially listed on the A-share market, marking several firsts in the industry, including being the first H-share new energy power central enterprise to return to A-shares [1] - Longyuan Power is a pioneer in wind power development in China, leading in offshore, low wind speed, and high altitude wind power sectors [1] - Since 2015, Longyuan Power has maintained its position as the world's largest wind power operator [1]

Investment Rating - The industry investment rating is "Positive" and is maintained [8] Core Insights - The report highlights that the AH premium rates for A/H listed pharmaceutical companies remain at a high level, with significant premiums observed for various innovative drug companies and CXO firms as of August 1, 2025 [2][6] - The report indicates a trend of narrowing AH premium rates, suggesting that leading companies like Heng Rui Medicine and WuXi AppTec have begun to achieve valuation recovery, with Heng Rui's H shares experiencing a reversal in AH premium [7][28] - The report anticipates that as Chinese innovative pharmaceutical companies continue to advance their R&D pipelines and internationalization efforts, the Hong Kong stock market may enter a value reassessment phase, revealing structural investment opportunities [2][28] Summary by Sections AH Premium Rates - As of August 1, 2025, the AH premium rates for several innovative drug companies are as follows: BeiGene at 47.56%, Junshi Biosciences at 70.30%, Innovent Biologics at 83.37%, Fudan-Zhangjiang at 185.15%, and Rongchang Biologics at 17.36% [6][17] - For CXO companies, the AH premium rates are: Zhaoyan New Drug at 52.67%, Tigermed at 36.50%, Kanglong Chemical at 51.60%, and Kelaiying at 20.21% [6][17] Trends in AH Premium Rates - The report notes a significant decrease in AH premium rates since early 2025, with leading companies like Heng Rui Medicine and WuXi AppTec achieving notable valuation adjustments [7][23] - The AH premium rates for these companies have shown a marked decline from earlier levels, indicating a shift in market dynamics [23][28] Investment Perspectives - The report emphasizes that the ongoing "tenglong huan niao" (transformation) in medical insurance will continue to unfold, with innovative drugs being a primary investment focus [30] - It suggests that companies with healthy cash flows, strong innovation capabilities, and established R&D platforms are well-positioned for growth [30] - The report also highlights the importance of breakthrough therapies and technological advancements, particularly in areas such as cytokine immunotherapy and PD1-based therapies [30]

Group 1 - The Shanghai Composite Index fell by 0.37% to close at 3559.95 points, while the Hang Seng Index decreased by 1.07% to 24507.81 points [1] - China Galaxy Securities Co., Ltd. has an AH premium of 79.1%, ranking 45th in terms of AH stock premium rates [1] - At the close, China Galaxy's A-shares were priced at 16.98 yuan, down 1.28%, and H-shares were at 10.32 Hong Kong dollars, down 2.82% [1] Group 2 - China Galaxy Securities is a leading comprehensive financial service provider in China's securities industry, known for its historical, brand, and shareholder advantages [1] - The company ranks among the top in the industry in terms of capital scale, profitability, business strength, and risk management capabilities [1] - It offers a wide range of financial services including wealth management, investment banking, institutional business, international business, and investment trading to individual, corporate, institutional, international, and capital market clients [1]

*注：AH股是指同时在A股和港股上市的公司，溢价（A/H）越大，说明H股相比A股越便宜。 本文源自：金融界 8月1日，上证指数跌0.37%，收报3559.95点，恒生指数跌1.07%，收报24507.81点。 复旦张江AH溢价达182.7%，位居AH股溢价率第四位。当日收盘，复旦张江A股报10.83元，涨幅 0.19%，H股报4.17港元，上涨1.96%。 资料显示，上海复旦张江生物医药股份有限公司,一九九六年十一月创建于上海浦东张江高科技园区,由 知名企业如上海医药集团股份有限公司等作为公司股东。本着"我们多一分探索、人类多一分健康"的信 念,公司主要从事生物医药的创新研究、开发、生产和销售,力求成为一家以知识产权为核心源泉的生物 医药创新企业。经过多年的不懈努力,公司在基因技术药物、光动力技术药物、纳米技术药物及口服固 体制剂技术药物等领域不断推出新技术及产品,形成了明显的竞争优势,预计未来将陆续有新药投放市 场。凭籍在生物医药领域的实力,公司多次承担"国家重点科技项目(攻关)计划"、"国家高技术研究发展 计划(八六三计划)"、"'重大新药创制'科技重大专项"等。 作者：行情君 ...

Group 1 - The Shanghai Composite Index fell by 0.37% to close at 3559.95 points, while the Hang Seng Index decreased by 1.07% to 24507.81 points [1] - China Merchants Industry Holdings Co., Ltd. (the "Company") has an A/H premium of 129.79%, ranking 15th among A/H shares [1] - The Company’s A-shares closed at 2.47 yuan, down 0.8%, and H-shares closed at 1.17 HKD, remaining flat [1] Group 2 - The Company is a subsidiary of China Ocean Shipping Group Co., Ltd. and specializes in shipping logistics and financial operations [1] - Established in 1997 and headquartered in Shanghai, the Company is listed in both Hong Kong and Shanghai [1] - The Company focuses on container manufacturing, leasing, and shipping leasing, supported by investment management for integrated development [1] - The container manufacturing business has an annual design capacity exceeding 1.4 million TEU, making it the second largest in the world [1] - The Company serves global renowned shipping lines and major leasing companies, enhancing its core competitiveness through technological innovation and green transformation [1]

Group 1 - The Shanghai Composite Index fell by 0.37% to close at 3559.95 points, while the Hang Seng Index decreased by 1.07% to 24507.81 points [1] - Hongye Futures has the highest A/H premium at 206.73%, indicating that its H-shares are relatively cheaper compared to A-shares [1] - Hongye Futures' A-shares closed at 11.92 yuan, down 0.58%, and its H-shares closed at 4.23 HKD, down 2.98% [1] Group 2 - Hongye Futures Co., Ltd. was established in 1995 and is a state-owned enterprise fully owned by Jiangsu Provincial State-owned Assets Supervision and Administration Commission [1] - The company operates in various sectors including commodity futures brokerage, financial futures brokerage, futures investment consulting, asset management, and fund sales, with 38 branches in major financial centers across China [1] - Hongye International Finance, a wholly-owned subsidiary, focuses on overseas securities and futures trading, asset management, and investment consulting, covering major global exchanges [1] - Hongye Capital, another wholly-owned risk management subsidiary, specializes in bulk commodity trading and risk management, serving as a market maker for multiple futures varieties [1] - The company has received several honors, including "National Civilized Unit" and "China's Best Futures Company" [1]

Group 1 - The Shanghai Composite Index fell by 0.37% to close at 3559.95 points, while the Hang Seng Index decreased by 1.07% to 24507.81 points [1] - Liaoning Port Co., Ltd. (referred to as Liao Port) has an AH premium of 103.1%, ranking 30th among AH shares [1] - Liao Port's A-shares closed at 1.53 yuan, while its H-shares closed at 0.82 Hong Kong dollars, both remaining flat [1] Group 2 - Liao Port was established from the merger of Dalian Port Co., Ltd. and Yingkou Port Co., Ltd. in February 2021, and it is the first port company in China to have both A and H share financing platforms [1] - The company's operations cover various cargo types including containers, oil products, bulk goods, and passenger roll-on/roll-off services, primarily located in four major port areas: Dalian and Yingkou [1] - Liao Port is one of the largest publicly listed companies in the northern region of China in terms of assets, revenue, and profit within the port industry [1]

Group 1: Southbound Capital Flow - Southbound capital has significantly increased, with a net purchase of HKD 201.84 billion on a single day, bringing the total net purchase for the year to HKD 8200.28 billion, surpassing last year's total of HKD 8079 billion, marking a historical high for the same period [1][2] - The southbound capital has been the strongest inflow into Hong Kong stocks this year, marking the 25th consecutive month of net purchases [3] Group 2: Bond Market Dynamics - The bond market is facing redemption pressure, with nearly HKD 1000 billion redeemed in a single day, the largest since January's market correction [7] - The yield on ten-year government bonds has risen from 1.66% to 1.75%, indicating a trend of increasing interest rates [7] - Insurance institutions have reduced their holdings in government bonds for three consecutive months, with reductions of HKD 89 million, HKD 74 million, and HKD 12 million in April, May, and June respectively [7] Group 3: Equity Fund Trends - The total scale of public funds in China reached a record high of CNY 34.39 trillion by the end of June, with mixed funds showing signs of recovery after a period of decline [11] - Mixed funds saw an increase of CNY 121.3 billion in scale, reaching CNY 3.68 trillion, with a slight increase in shares [11][13] - The issuance of new mixed funds in June was significant, with 155 new funds launched, totaling 122.12 billion shares [11][13] Group 4: Money Market Fund Performance - Money market funds experienced a decline in both scale and shares in June, with reductions of CNY 167.5 billion and 164.5 billion shares respectively [15] - The yield on the largest money market fund, Yu'e Bao, has decreased from 1.58% in February to 1.09%, nearing a drop below 1% [15]

Core Viewpoint - The inclusion of companies listed in both A-share and H-share markets (A+H companies) in the Hong Kong Stock Connect is increasing, reflecting a growing trend of A-share companies seeking to list in Hong Kong and the positive market response to these listings [1][11][12]. Group 1: Recent Developments - On July 21, the Shenzhen Stock Exchange announced the adjustment of the Hong Kong Stock Connect eligible securities list, adding Sanhua Intelligent Control, which has recently completed its listing on the Hong Kong Stock Exchange [1][4]. - This year, several A+H companies, including Chifeng Jilong Gold, Junda Co., Ningde Times, and others, have been added to the Hong Kong Stock Connect [2][7]. Group 2: Market Trends - As of July 18, 156 out of 160 A+H companies have been included in the Hong Kong Stock Connect, accounting for 28% of all eligible securities [8]. - The trend of A-share companies listing in Hong Kong has been on the rise, with 10 companies having completed listings in Hong Kong this year alone [12][14]. Group 3: Regulatory Environment - Regulatory improvements have been a significant driver for A-share companies to list in Hong Kong, including measures from the China Securities Regulatory Commission to expedite the approval process for companies seeking to list abroad [15]. - The Hong Kong Stock Exchange has also introduced measures to attract A-share companies, such as a fast-track review process for companies with a market capitalization exceeding HKD 10 billion [15]. Group 4: Market Dynamics - Unlike previous trends where H-share prices were lower than A-share prices, many A+H companies have seen their H-share prices exceed A-share prices this year, boosting confidence in A-share companies listing in Hong Kong [17]. - As of July 18, 155 A+H companies have a premium on their H-shares compared to A-shares, indicating a shift in market dynamics [18].

Core Viewpoint - Anker Innovations is exploring equity financing in the Hong Kong capital market, reflecting a growing trend of A-share companies listing in Hong Kong, with 10 companies having done so by July 17 this year [1] Group 1: A-share Companies Listing in Hong Kong - There has been a surge in A-share companies listing in Hong Kong, with 41 companies currently processing their listing applications as of mid-July [4] - The increase in A-share companies seeking to list in Hong Kong is attributed to policy support and the need for companies to expand their financing channels and international presence [4][6] - The Hong Kong IPO market has seen significant activity, with the total fundraising amount leading globally in the first half of the year [4] Group 2: Characteristics of Newly Listed A+H Companies - The newly listed A+H companies in Hong Kong this year are characterized by high market capitalization, with 9 out of 10 having a market value exceeding 10 billion yuan, and 5 exceeding 100 billion yuan [7] - These companies have demonstrated strong dividend capabilities and a focus on technology, enhancing their influence on the Hong Kong market [7] - A significant portion of the A+H companies are state-owned enterprises, with 68.13% of the 160 A+H companies being state-owned as of July 17 [7] Group 3: AH Share Premium Trends - The AH share premium has been on a downward trend, with 96.88% of A+H companies showing a premium of A-shares over H-shares as of July 17 [8] - The Hang Seng Shanghai-Shenzhen-Hong Kong Stock Connect AH share premium index was reported at 127.65, indicating that A-shares are, on average, 27% higher than H-shares [8] - The decline in AH share premium is attributed to differences in investor structure and trading mechanisms between A-shares and H-shares [8][9] Group 4: Future Outlook - It is anticipated that the trend of A-share companies listing in Hong Kong will continue over the next 2 to 3 years, supported by ongoing regulatory optimizations and market synergies [5][6] - The AH share premium is expected to continue narrowing, with factors such as increased southbound capital inflow and improved market conditions contributing to this trend [9]